On the morning of Saturday, October 21, the 5th edition of Sinergia will bring the science of the Bellvitge Campus closer to citizens.
Sinergia will open its doors to Bellvitge health research and innovation Read More »
When the RANK protein was suppressed in luminal cells of the breast tissue in female mice, they did not produce milk in their first pregnancy.
ADmit Therapeutics is a biotechnology company founded at the end of 2017 as a spin-off from the Bellvitge Biomedical Research Institute (IDIBELL). The company is focused on the development and commercialization of a new early detection technology for Alzheimer’s disease (AD) and has successfully closed a €5.4 million equity round.
The IDIBELL’s spin-off ADmit therapeutics closes a €5.4 million funding round Read More »
The study has been published in the journal Nature Medicine, one of the most prestigious in Medicine, and represents a step forward to address an important health challenge worldwide, with high rates of therapeutic failure and mortality.
Research led in Bellvitge will allow progress in the fight against bacteremia Read More »
A study by IDIBELL and ICO in 7,202 women with endometrial cancer and more than 22,000 control women found no relationship between lack of sleep or working night shifts with the development of this cancer.
The study performs an evaluation to determine the cost-effectiveness and profitability of two strategies for the early detection of endometrial cancer in women with postmenopausal bleeding.
1 in 3 men over the age of 15 are infected with at least one genital human papillomavirus (HPV) type, and 1 in 5 are infected with one or more of what are known as high risk, or oncogenic, HPV types
One in three men worldwide are infected with genital human papillomavirus Read More »
A research team led by Aurora Pujol and Dr. Carlos Casasnovas developed an innovative computational algorithm called ClinPrior. This algorithm demonstrated its ability to improve the diagnosis rate in patients with rare diseases of genetic origin.
A new clinical algorithm increases the diagnosis rate of rare diseases Read More »
This work, in which IDIBELL and the Catalan Institute of Oncology (ICO) participated, has analyzed the concentrations of nicotine in the air, as well as, cotinine and nitrosamines, specifically of tobacco dust in vehicles.
Study shows the health risk of smoking in the car Read More »
A new study published and highlighted by the scientific journal Emergencias reveals the direct relationship between having two or more factors, such as illiteracy, anxiety or lack of caregivers, and returning to the ER in less than 30 days.
